Antoni Bayés-Genis Selected Research

Antoni Bayés-Genis Research Topics

13	Heart Failure 11/2023 - 01/2018
2	Hypertrophy 05/2024 - 11/2023
2	Iron Deficiencies 11/2023 - 10/2020
2	Infarction (Infarctions) 01/2021 - 12/2019
1	Cardiomyopathies (Cardiomyopathy) 05/2024
1	Cardiomegaly (Heart Hypertrophy) 11/2023
1	Alcoholic Cardiomyopathy 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Disease Progression 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Myocardial Infarction 01/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Anemia 10/2020
1	Stroke (Strokes) 01/2020
1	Pulmonary Hypertension 06/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Cardiac Arrhythmias (Arrythmia) 11/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2009

3	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2018
2	dapagliflozinIBA 11/2023 - 01/2023
2	Natriuretic PeptidesIBA 01/2023 - 01/2018
2	Neprilysin (Neutral Endopeptidase)IBA 01/2021 - 01/2021
2	IronIBA 10/2020 - 01/2018
2	CarbohydratesIBA 01/2018 - 01/2018
1	empagliflozinIBA 05/2024
1	N-propionylprocainamideIBA 11/2023
1	Atrial Natriuretic Factor (ANF)IBA 11/2023
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	SodiumIBA 07/2021
1	DiureticsIBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	AldosteroneIBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	Ferritins (Ferritin)IBA 10/2020
1	Transferrin (beta 2 Transferrin)IBA 10/2020
1	2'- methylspiro- (1- azabicyclo(2.2.2.)octane- 3,4'- (1,3)- dioxolane) (AF-30)IBA 01/2020
1	Contrast MediaIBA 12/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 11/2009

4	Therapeutics 01/2021 - 01/2018
1	Transcatheter Aortic Valve Replacement 01/2022
1	Percutaneous Coronary Intervention 01/2021
1	Patient Readmission 01/2018